Míron Smelt Munndreifitafla 15 mg Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

míron smelt munndreifitafla 15 mg

teva b.v.* - mirtazapinum inn - munndreifitafla - 15 mg

Míron Smelt Munndreifitafla 30 mg Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

míron smelt munndreifitafla 30 mg

teva b.v.* - mirtazapinum inn - munndreifitafla - 30 mg

NeisVac-C Stungulyf, dreifa Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

neisvac-c stungulyf, dreifa

pfizer aps - neisseria meningitidis c (oligosakkaríð eða polýsakkaríð) - stungulyf, dreifa

NuvaRing Leggangainnlegg 0,120 mg/0,015 mg/24 klst. Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

nuvaring leggangainnlegg 0,120 mg/0,015 mg/24 klst.

n.v. organon* - etonogestrelum inn; ethinylestradiolum inn - leggangainnlegg - 0,120 mg/0,015 mg/24 klst.

Ornibel Leggangainnlegg 0,120mg / 0,015 mg/24 klst. Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

ornibel leggangainnlegg 0,120mg / 0,015 mg/24 klst.

exeltis healthcare s.l. - etonogestrelum inn; ethinylestradiolum inn - leggangainnlegg - 0,120mg / 0,015 mg/24 klst.

Saizen (Saizen LQ) Stungulyf, lausn í rörlykju 5,83 mg/ml Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

saizen (saizen lq) stungulyf, lausn í rörlykju 5,83 mg/ml

merck ab - somatropinum inn - stungulyf, lausn í rörlykju - 5,83 mg/ml

Saizen (Saizen LQ) Stungulyf, lausn í rörlykju 8 mg/ml Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

saizen (saizen lq) stungulyf, lausn í rörlykju 8 mg/ml

merck ab - somatropinum inn - stungulyf, lausn í rörlykju - 8 mg/ml

Metadon 2care4 Tafla 10 mg Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

metadon 2care4 tafla 10 mg

2care4 generics aps - methadonum hýdróklóríð - tafla - 10 mg

Metadon 2care4 Tafla 5 mg Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

metadon 2care4 tafla 5 mg

2care4 generics aps - methadonum hýdróklóríð - tafla - 5 mg

Cimzia Европейский союз - исландский - EMA (European Medicines Agency)

cimzia

ucb pharma sa - certolizumab pegol - crohn disease - Ónæmisbælandi lyf - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. Þegar hægt er að gefa eitt og sér í málið óþol stendur eða þegar áframhaldandi meðferð með stendur er óviðeigandi. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.